PRAMIPEXOLE XR GP pramipexole dihydrochloride monohydrate 2.25 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pramipexole xr gp pramipexole dihydrochloride monohydrate 2.25 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 2.25 mg - tablet, modified release - excipient ingredients: hypromellose; calcium hydrogen phosphate; silicon dioxide; magnesium stearate - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.

PRAMIPEXOLE XR GP pramipexole dihydrochloride monohydrate 0.75 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pramipexole xr gp pramipexole dihydrochloride monohydrate 0.75 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 0.75 mg - tablet, modified release - excipient ingredients: magnesium stearate; silicon dioxide; hypromellose; calcium hydrogen phosphate - for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.

APO-PRAMIPEXOLE pramipexole dihydrochloride monohydrate 1 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-pramipexole pramipexole dihydrochloride monohydrate 1 mg tablet blister pack

southern cross pharma pty ltd - pramipexole dihydrochloride monohydrate, quantity: 1 mg - tablet - excipient ingredients: pregelatinised maize starch; mannitol; microcrystalline cellulose; povidone; purified talc; magnesium stearate - the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa. the symptomatic treatment of primary restless legs syndrome.

APO-PRAMIPEXOLE pramipexole dihydrochloride monohydrate 0.25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-pramipexole pramipexole dihydrochloride monohydrate 0.25 mg tablet blister pack

southern cross pharma pty ltd - pramipexole dihydrochloride monohydrate, quantity: 0.25 mg - tablet - excipient ingredients: pregelatinised maize starch; mannitol; microcrystalline cellulose; povidone; purified talc; magnesium stearate - the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa. the symptomatic treatment of primary restless legs syndrome.

APO-PRAMIPEXOLE pramipexole dihydrochloride monohydrate 0.125 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-pramipexole pramipexole dihydrochloride monohydrate 0.125 mg tablet blister pack

southern cross pharma pty ltd - pramipexole dihydrochloride monohydrate, quantity: 0.125 mg - tablet - excipient ingredients: pregelatinised maize starch; mannitol; microcrystalline cellulose; povidone; purified talc; magnesium stearate - the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa. the symptomatic treatment of primary restless legs syndrome.